Geneos Wealth Management’s NYLIM Merger Arbitrage ETF MNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-191
Closed -$6K – 2191
2023
Q4
$6K Buy
+191
New +$5.99K ﹤0.01% 1685
2022
Q2
– Sell
-178
Closed -$5K – 2708
2022
Q1
$5K Buy
+178
New +$5.67K ﹤0.01% 2343
2021
Q3
– Sell
-663
Closed -$22K – 2878
2021
Q2
$22K Sell
663
-86
-11% -$2.88K ﹤0.01% 1875
2021
Q1
$25K Sell
749
-83
-10% -$2.75K ﹤0.01% 1957
2020
Q4
$24K Buy
832
+76
+10% +$2.58K ﹤0.01% 1798
2020
Q3
$24K Sell
756
-50
-6% -$1.61K ﹤0.01% 1577
2020
Q2
$25K Hold
806
– – ﹤0.01% 1523
2020
Q1
$24K Buy
806
+756
+1,512% +$24.4K ﹤0.01% 1435
2019
Q4
$1K Sell
50
-1,881
-97% -$61.4K ﹤0.01% 2484
2019
Q3
$61K Hold
1,931
– – ﹤0.01% 1088
2019
Q2
$60K Buy
1,931
+197
+11% +$6.25K ﹤0.01% 1104
2019
Q1
$55K Buy
+1,734
New +$55.6K ﹤0.01% 1093

Other funds holding MNA

Geneos Wealth Management's MNA Position: Q1 2024 in Review

Geneos Wealth Management sold out of NYLIM Merger Arbitrage ETF (MNA) in Q1 2024, closing a stake of 191 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in MNA in Q1 2019 and held it in 12 quarters. The position peaked at $61K in Q3 2019. 78 funds tracked by Wall St. Rank hold MNA as of Q1 2024.

  • Geneos Wealth Management reported no remaining NYLIM Merger Arbitrage ETF position as of Q1 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 191 NYLIM Merger Arbitrage ETF shares in Q1 2024, an estimated $6K.
  • Geneos Wealth Management first reported a position in NYLIM Merger Arbitrage ETF in Q1 2019 and held it in 12 quarters.
  • Geneos Wealth Management's NYLIM Merger Arbitrage ETF position peaked at $61K in Q3 2019.
  • 78 funds tracked by Wall St. Rank held NYLIM Merger Arbitrage ETF as of Q1 2024.

Based on Geneos Wealth Management's 13F filing for Q1 2024, filed 3 May 2024.